1. Home
  2. TKLF vs NRSN Comparison

TKLF vs NRSN Comparison

Compare TKLF & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yoshitsu Co. Ltd

TKLF

Yoshitsu Co. Ltd

N/A

Current Price

$3.09

Market Cap

15.6M

ML Signal

N/A

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.90

Market Cap

26.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKLF
NRSN
Founded
2006
2017
Country
Japan
Israel
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
26.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
TKLF
NRSN
Price
$3.09
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$14.00
AVG Volume (30 Days)
28.4K
329.1K
Earning Date
12-19-2025
04-06-2026
Dividend Yield
7.81%
N/A
EPS Growth
N/A
N/A
EPS
1.05
N/A
Revenue
$302,537,158.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.94
N/A
Revenue Growth
37.82
N/A
52 Week Low
$2.10
$0.68
52 Week High
$4.32
$2.60

Technical Indicators

Market Signals
Indicator
TKLF
NRSN
Relative Strength Index (RSI) 63.27 50.42
Support Level $2.97 $0.81
Resistance Level $3.22 $0.90
Average True Range (ATR) 0.21 0.08
MACD 0.07 0.02
Stochastic Oscillator 89.25 86.35

Price Performance

Historical Comparison
TKLF
NRSN

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: